Described herein are pharmaceutical packaging devices which reduce oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate drugs, this kind of units like a syringe with the oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with pretty minimal permeability to oxygen and comprises ethyle